MY-673 is used as a colchicine-binding site inhibitor (CBSI) to suppress tubulin polymerization; it inhibits the ERK signaling pathway, thereby modulating SMAD4 protein expression in the TGF-β/SMAD pathway; it effectively suppresses cell proliferation and migration, and induces apoptosis in vitro and in vivo.